Literature DB >> 23867221

MicroRNA-124 regulates osteoclast differentiation.

Youngkyun Lee1, Hyo Jeong Kim, Cheol Kyu Park, Yong-Gun Kim, Heon-Jin Lee, Jae-Young Kim, Hong-Hee Kim.   

Abstract

Osteoclasts are specialized cells for bone-resorption originated from precursors of macrophage/monocyte lineage. The receptor activator of NFκB ligand (RANKL) initiates osteoclast differentiation, in which nuclear factor of activated T cell cytoplasmic 1 (NFATc1) plays a key role as a master transcription factor. In the present report, we show that microRNA-124 (miR-124) regulates osteoclastogenesis of mouse bone marrow macrophages (BMMs) by suppressing NFATc1 expression. On the other hand, synthetic inhibitor that binds specifically to miR-124 enhanced osteoclast differentiation and NFATc1 expression. The overexpression of a constitutively active form of NFATc1 prevented the inhibitory effect of miR-124 on osteoclastogenesis. Finally, miR-124 also affected the proliferation and motility of osteoclast precursors, the latter coinciding with the reduced expression of RhoA and Rac1. These findings not only reveal unprecedented role of miR-124 in osteoclastogenesis but also suggest a novel mode of regulation of NFATc1 in osteoclasts.
© 2013.

Entities:  

Keywords:  Differentiation; NFATc1; Osteoclast; miR-124

Mesh:

Substances:

Year:  2013        PMID: 23867221     DOI: 10.1016/j.bone.2013.07.007

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  51 in total

Review 1.  MicroRNA variants as genetic determinants of bone mass.

Authors:  Neha S Dole; Anne M Delany
Journal:  Bone       Date:  2015-12-23       Impact factor: 4.398

2.  MiR-30a attenuates osteoclastogenesis via targeting DC-STAMP-c-Fos-NFATc1 signaling.

Authors:  Yiran Yin; Lian Tang; Jieying Chen; Xiaobo Lu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

3.  High-Throughput Fluorescence-Based Screen Identifies the Neuronal MicroRNA miR-124 as a Positive Regulator of Alphavirus Infection.

Authors:  Paula López; Erika Girardi; Bryan C Mounce; Amélie Weiss; Béatrice Chane-Woon-Ming; Mélanie Messmer; Pasi Kaukinen; Arnaud Kopp; Diane Bortolamiol-Becet; Ali Fendri; Marco Vignuzzi; Laurent Brino; Sébastien Pfeffer
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

Review 4.  Deregulation and therapeutic potential of microRNAs in arthritic diseases.

Authors:  Rita Vicente; Danièle Noël; Yves-Marie Pers; Florence Apparailly; Christian Jorgensen
Journal:  Nat Rev Rheumatol       Date:  2015-12-24       Impact factor: 20.543

5.  MicroRNA-124 inhibits TNF-α- and IL-6-induced osteoclastogenesis.

Authors:  Kenichiro Ohnuma; Shimpei Kasagi; Kenichi Uto; Yoriko Noguchi; Yuji Nakamachi; Jun Saegusa; Seiji Kawano
Journal:  Rheumatol Int       Date:  2018-12-14       Impact factor: 2.631

Review 6.  Osteoclastic microRNAs and their translational potential in skeletal diseases.

Authors:  Kazuki Inoue; Shinichi Nakano; Baohong Zhao
Journal:  Semin Immunopathol       Date:  2019-10-07       Impact factor: 9.623

7.  Calvarial bone development and suture closure in Dicer-deficient mice.

Authors:  P Atsawasuwan; M Ouibaidin; B Dalal; H Khan; A Mohammed
Journal:  Orthod Craniofac Res       Date:  2017-06       Impact factor: 1.826

8.  Systemic investigation of bone and muscle abnormalities in dystrophin/utrophin double knockout mice during postnatal development and the mechanisms.

Authors:  Xueqin Gao; Ying Tang; Sarah Amra; Xuying Sun; Yan Cui; Haizi Cheng; Bing Wang; Johnny Huard
Journal:  Hum Mol Genet       Date:  2019-05-15       Impact factor: 6.150

9.  Silk Biomaterials-Mediated miRNA Functionalized Orthopedic Devices.

Authors:  Eric N James; Emily Van Doren; Chunmei Li; David L Kaplan
Journal:  Tissue Eng Part A       Date:  2018-08-22       Impact factor: 3.845

Review 10.  Osteoclastogenesis in periodontal diseases: Possible mediators and mechanisms.

Authors:  Mohammed S AlQranei; Meenakshi A Chellaiah
Journal:  J Oral Biosci       Date:  2020-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.